Cargando…
A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer
BACKGROUND: Breast cancer is the most prevalent malignancy worldwide and the leading culprit for women’s death. Cuproptosis is a novel and promising modality of tumor cell death and the relationship with long non-coding RNAs (lncRNAs) remains shrouded in a veil. Studies in cuproptosis-related lncRNA...
Autores principales: | Yu, Hao, Liu, Yanbiao, Zhang, Wenrong, Peng, Ziqi, Yu, Xinmiao, Jin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331703/ https://www.ncbi.nlm.nih.gov/pubmed/37434691 http://dx.doi.org/10.21037/tcr-22-2702 |
Ejemplares similares
-
LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023) -
Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023) -
A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023) -
Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
por: Zhang, Tong, et al.
Publicado: (2023) -
Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)